Mark L. Peterson

1.4k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Mark L. Peterson is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Mark L. Peterson has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 3 papers in Infectious Diseases. Recurrent topics in Mark L. Peterson's work include Biochemical and Molecular Research (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Chemical Synthesis and Analysis (3 papers). Mark L. Peterson is often cited by papers focused on Biochemical and Molecular Research (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Chemical Synthesis and Analysis (3 papers). Mark L. Peterson collaborates with scholars based in United States, Canada and Netherlands. Mark L. Peterson's co-authors include Éric Marsault, Robert Vince, Dian-Shi Wang, Irene Lecker, Beverley A. Orser, Alexander D. Romaschin, C. David Mazer, Donald S. Matteson, Erik Christenson and Ender Erdık and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

Mark L. Peterson

12 papers receiving 995 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery

2011 683 citations Éric Marsault, Mark L. Peterson Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark L. Peterson United States	9	604	554	112	78	77	14	1.0k
Sylvain Broussy France	16	424 0.7×	218 0.4×	41 0.4×	75 1.0×	12 0.2×	37	724
Julie A. Krueger United States	18	394 0.7×	237 0.4×	39 0.3×	198 2.5×	10 0.1×	31	906
Arindam Talukdar India	16	406 0.7×	284 0.5×	51 0.5×	96 1.2×	9 0.1×	46	839
Jeffrey R. Spencer United States	16	326 0.5×	315 0.6×	58 0.5×	79 1.0×	8 0.1×	30	721
Pierre Deprez Belgium	18	533 0.9×	445 0.8×	85 0.8×	263 3.4×	8 0.1×	58	1.4k
Giovanni Marzaro Italy	21	578 1.0×	609 1.1×	85 0.8×	175 2.2×	6 0.1×	80	1.4k
Harold R. Almond United States	18	590 1.0×	472 0.9×	150 1.3×	68 0.9×	6 0.1×	32	1.2k
Stefano Guglielmo Italy	20	238 0.4×	356 0.6×	50 0.4×	158 2.0×	10 0.1×	45	868
Francesco Bondavalli Italy	27	581 1.0×	1.6k 2.9×	234 2.1×	160 2.1×	7 0.1×	104	2.0k
Daniel H. O’Donovan United Kingdom	16	451 0.7×	301 0.5×	31 0.3×	138 1.8×	11 0.1×	27	833

Countries citing papers authored by Mark L. Peterson

Since Specialization

Citations

This map shows the geographic impact of Mark L. Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Peterson more than expected).

Fields of papers citing papers by Mark L. Peterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Peterson. The network helps show where Mark L. Peterson may publish in the future.

Co-authorship network of co-authors of Mark L. Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Peterson. A scholar is included among the top collaborators of Mark L. Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Peterson. Mark L. Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Stevers, Loes M., M. Wolter, Graeme W. Carlile, et al.. (2022). Macrocycle-stabilization of its interaction with 14-3-3 increases plasma membrane localization and activity of CFTR. Nature Communications. 13(1). 3586–3586. 20 indexed citations

Lecker, Irene, Dian-Shi Wang, Alexander D. Romaschin, et al.. (2012). Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. Journal of Clinical Investigation. 122(12). 4654–4666. 134 indexed citations

Marsault, Éric & Mark L. Peterson. (2011). Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery. Journal of Medicinal Chemistry. 54(7). 1961–2004. 683 indexed citations breakdown →

Marsault, Éric, Hamid R. Hoveyda, Mark L. Peterson, et al.. (2006). Discovery of a New Class of Macrocyclic Antagonists to the Human Motilin Receptor. Journal of Medicinal Chemistry. 49(24). 7190–7197. 36 indexed citations

Sikorski, James A., et al.. (1999). New 4-(α-Hetero-Phosphonomethyl) Pyrrole 2-Carboxylates are EPSP Synthase Inhibitors. Phosphorus, sulfur, and silicon and the related elements. 144(1). 617–620.

Peterson, Mark L., et al.. (1998). Deconvolution by omission libraries. Bioorganic & Medicinal Chemistry Letters. 8(17). 2357–2362. 4 indexed citations

Peterson, Mark L., et al.. (1997). ChemInform Abstract: New Simplified Inhibitors of EPSP Synthase: The Importance of Ring Size for Recognition at the Shikimate 3‐Phosphate Site.. ChemInform. 28(16). 1 indexed citations

Peterson, Mark L., et al.. (1996). New simplified inhibitors of EPSP synthase: The importance of ring size for recognition at the shikimate 3-phosphate site. Bioorganic & Medicinal Chemistry Letters. 6(23). 2853–2858. 11 indexed citations

Peterson, Mark L. & Robert Vince. (1991). Synthesis and biological evaluation of 4-purinylpyrrolidine nucleosides. Journal of Medicinal Chemistry. 34(9). 2787–2797. 78 indexed citations

10.

Peterson, Mark L. & Robert Vince. (1990). Synthesis and biological evaluation of carbocyclic analogs of lyxofuranosides of 2-amino-6-substituted purines and 2-amino-6-substituted-8-azapurines. Journal of Medicinal Chemistry. 33(4). 1214–1219. 20 indexed citations

11.

Matteson, Donald S. & Mark L. Peterson. (1988). ChemInform Abstract: Synthesis of L‐(+)‐Ribose via (S)‐Pinanediol (αS)‐α‐Bromo Boronic Esters.. ChemInform. 19(17). 1 indexed citations

12.

Matteson, Donald S., et al.. (1988). A chiral synthesis of (2S, 3S)‐phenylalanine‐3‐²H via boronic esters. Journal of Labelled Compounds and Radiopharmaceuticals. 25(6). 675–683. 17 indexed citations

13.

Matteson, Donald S., K. M. SADHU, Rahul Ray, et al.. (1985). Directed asymmetric synthesis with boronic esters. Journal of Organometallic Chemistry. 281(1). 15–23. 6 indexed citations

14.

Matteson, Donald S., K. M. SADHU, Ritwika Ray, et al.. (1985). Asymmetric synthesis with boronic esters. Pure and Applied Chemistry. 57(12). 1741–1748. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact